Novavax Inc. Stock Underperforms Thursday When Compared To Competitors
I'm PortAI, I can summarize articles.
Novavax Inc. (NVAX) shares fell 4.84% to $7.87 on Thursday, marking the fifth consecutive day of losses. The stock is now 26.07% below its 52-week high of $10.64. In contrast, competitors like Johnson & Johnson and Merck saw gains, while Pfizer experienced a slight decline. The NASDAQ Composite Index dropped 1.59% and the Dow Jones Industrial Average fell 1.20%. Trading volume was below the 50-day average.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments